{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:27:16Z","timestamp":1786688836722,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (MPP) is common in children, but severe MPP (SMPP) may progress rapidly and is difficult to distinguish from non-severe disease because clinical, laboratory, and radiographic findings overlap. We aimed to develop and internally validate machine-learning models for adjunctive SMPP risk stratification using routine data while minimizing circular reasoning.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively included consecutive children with MPP admitted from January 1, 2015, to January 1, 2026. Demographic, clinical, laboratory, and radiographic variables were collected. Variables overlapping with the severity definition, severity-proximal biomarkers, and model-derived leakage variables were excluded before modeling. Eight supervised algorithms were developed in a training cohort and evaluated in an internal test cohort using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, F1-score, calibration, Brier score, and decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 1,046 children, of whom 205 had SMPP; 784 were assigned to the training set and 262 to the internal test set, including 51 SMPP cases. In the strict non-overlap test set, the support vector machine achieved the highest AUC of 0.947 [95% confidence interval (CI), 0.907\u20130.980], with accuracy of 0.924, sensitivity of 0.784, specificity of 0.957, F1-score of 0.800, and Brier score of 0.058. Random forest achieved an AUC of 0.926 (95% CI, 0.878\u20130.964), accuracy of 0.897, sensitivity of 0.824, specificity of 0.915, and Brier score of 0.094. It was retained for calibration, decision-curve, threshold, and feature-importance analyses because of its interpretability and balanced performance. Important predictors included aspartate aminotransferase, alanine aminotransferase, albumin, cough duration, blood urea nitrogen, white blood cell count, platelet count, age, wheezing, and lung rales.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After exclusion of leakage variables and severity-definition-overlapping predictors, machine-learning models maintained good internal performance for classifying SMPP in children with MPP. They should be considered adjunctive risk-stratification tools rather than standalone early diagnostic tools. Multicenter external validation and prospective workflow evaluation are required before clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1895967","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:33:12Z","timestamp":1786685592000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Explainable machine learning for diagnosing severe Mycoplasma pneumoniae pneumonia in children: model development and internal validation"],"prefix":"10.3389","volume":"14","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Third People\u2019s Hospital of Chengdu","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Third People\u2019s Hospital of Chengdu","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Third People\u2019s Hospital of Chengdu","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Third People\u2019s Hospital of Chengdu","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12879-024-09340-x","article-title":"A comparative study of general and severe Mycoplasma pneumoniae pneumonia in children","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12887-025-05804-4","article-title":"Comparative analysis of the clinical characteristics of severe Mycoplasma pneumoniae pneumonia and severe bacterial pneumonia in children","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40121-023-00914-x","article-title":"Clinical characteristics of lung consolidation with Mycoplasma pneumoniae pneumonia and risk factors for Mycoplasma pneumoniae necrotizing pneumonia in children","volume":"13","author":"Zhang","year":"2024","journal-title":"Infect Dis Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e39665","DOI":"10.1097\/MD.0000000000039665","article-title":"Prospective cohort study on the clinical significance of interferon-gamma, D-dimer, LDH, and CRP tests in children with severe mycoplasma pneumonia","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.12998\/wjcc.v12.i22.4940","article-title":"Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma severity","volume":"12","author":"Wang","year":"2024","journal-title":"World J Clin Cases"},{"key":"B6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12931-025-03262-1","article-title":"Development and validation of an early diagnosis model for severe mycoplasma pneumonia in children based on interpretable machine learning","volume":"26","author":"Xie","year":"2025","journal-title":"Respir Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12879-025-10958-8","article-title":"A machine learning model for predicting severe mycoplasma pneumoniae pneumonia in school-aged children","volume":"25","author":"Ye","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.21037\/tp-2024-562","article-title":"Development and validation of a machine learning model for predicting co-infection of Mycoplasma pneumonia in pediatric patients","volume":"14","author":"Liu","year":"2025","journal-title":"Transl Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"Br Med J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e082505","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST\u2009+\u2009AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"Br Med J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/postmj\/qgae027","article-title":"Understanding decision curve analysis in clinical prediction model research","volume":"100","author":"Zhao","year":"2024","journal-title":"Postgrad Med J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1585042","DOI":"10.3389\/fpubh.2025.1585042","article-title":"Building a diagnostic prediction model for severe Mycoplasma pneumoniae pneumonia in children using machine learning","volume":"13","author":"Gong","year":"2025","journal-title":"Front Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18029","DOI":"10.1038\/s41598-025-02962-4","article-title":"Predicting and interpreting key features of refractory Mycoplasma pneumoniae pneumonia using multiple machine learning methods","volume":"15","author":"Jiang","year":"2025","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"16172","DOI":"10.1038\/s41598-024-67255-8","article-title":"Model based on the automated AI-driven CT quantification is effective for the diagnosis of refractory Mycoplasma pneumoniae pneumonia","volume":"14","author":"Qian","year":"2024","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1038\/s41598-024-58784-3","article-title":"A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1735063","DOI":"10.3389\/fped.2026.1735063","article-title":"Nomogram to predict severe Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"2026","journal-title":"Front Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9803","DOI":"10.1038\/s41598-024-60359-1","article-title":"Predictive value of lactate dehydrogenase for Mycoplasma pneumoniae necrotizing pneumonia in children based on decision curve analysis and dose-response analysis","volume":"14","author":"Yanhong","year":"2024","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","article-title":"Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1489389","DOI":"10.3389\/fped.2024.1489389","article-title":"Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study","volume":"12","author":"Li","year":"2024","journal-title":"Front Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/microorganisms12091806","article-title":"Clinical manifestations, macrolide resistance, and treatment utilization trends of Mycoplasma pneumoniae pneumonia in children and adolescents in South Korea","volume":"12","author":"Lee","year":"2024","journal-title":"Microorganisms"},{"key":"B21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s13312-025-00190-7","article-title":"Effect of macrolide resistance and Mycoplasma pneumoniae DNA load in bronchoalveolar lavage fluid on immune and inflammatory responses in children with Mycoplasma pneumoniae pneumonia","volume":"62","author":"Zhong","year":"2025","journal-title":"Indian Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10096-025-05142-4","article-title":"A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults after the COVID-19 pandemic","volume":"44","author":"Yue","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/IDR.S502937","article-title":"Clinical characteristics and treatment outcomes of pediatric drug-resistant Mycoplasma pneumoniae pneumonia in the post-COVID-19 era","volume":"18","author":"Sun","year":"2025","journal-title":"Infect Drug Resist"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0245825","DOI":"10.1128\/spectrum.02458-25","article-title":"A machine learning-based predictive model for multilobar pulmonary consolidation induced by macrolide-resistant Mycoplasma pneumoniae pneumonia caused by the 23S rRNA A2063G mutation","volume":"13","author":"Guo","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1186\/s12879-024-09613-5","article-title":"A preliminary prediction model of pediatric Mycoplasma pneumoniae pneumonia based on routine blood parameters by using machine learning method","volume":"24","author":"Peng","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1785189","DOI":"10.3389\/fcimb.2026.1785189","article-title":"Early prediction of plastic bronchitis in pediatric patients with Mycoplasma pneumoniae pneumonia by interpretable machine learning algorithms","volume":"16","author":"Wang","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1755878","DOI":"10.3389\/fdgth.2026.1755878","article-title":"Machine learning prediction of oxygen therapy in pediatric Mycoplasma pneumoniae pneumonia","volume":"8","author":"Coppola","year":"2026","journal-title":"Front Digit Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1695974","DOI":"10.3389\/fped.2025.1695974","article-title":"Development and validation of a nomogram for early prediction of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children","volume":"13","author":"Liu","year":"2025","journal-title":"Front Pediatr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12879-025-11584-0","article-title":"Clinical characteristics of Mycoplasma pneumoniae pneumonia in children with 23S rRNA mutations in domain V and exploration of the timing of glucocorticoid therapy","volume":"25","author":"Shen","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1388132","DOI":"10.3389\/fped.2024.1388132","article-title":"Impact of the COVID-19 pandemic on epidemiological and clinical characteristics of Mycoplasma pneumoniae pneumonia in children: a multicenter study from Hubei, China","volume":"12","author":"Du","year":"2024","journal-title":"Front Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1895967\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:33:13Z","timestamp":1786685593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1895967\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":30,"alternative-id":["10.3389\/fped.2026.1895967"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1895967","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1895967"}}